
Acasti Pharma Inc. – NASDAQ:ACST
Acasti Pharma stock price monthly change
Acasti Pharma stock price quarterly change
Acasti Pharma stock price yearly change
Acasti Pharma key metrics
Market Cap | 34.17M |
Enterprise value | N/A |
P/E | -1.34 |
EV/Sales | N/A |
EV/EBITDA | 0.35 |
Price/Sales | N/A |
Price/Book | 0.21 |
PEG ratio | -0.01 |
EPS | -1.58 |
Revenue | N/A |
EBITDA | -12.01M |
Income | -13.29M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeAcasti Pharma stock price history
Acasti Pharma stock forecast
Acasti Pharma financial statements
Jun 2023 | 0 | -4.02M | |
---|---|---|---|
Sep 2023 | 0 | -3.71M | |
Dec 2023 | 0 | -2.39M | |
Mar 2024 | 0 | -3.16M |
Sep 2025 | 0 | -3.68M | |
---|---|---|---|
Oct 2025 | 0 | -3.01M | |
Dec 2025 | 0 | -3.63M | |
Mar 2026 | 0 | -4.30M |
Analysts Price target
Financials & Ratios estimates
Jun 2023 | 73033000 | 9.02M | 12.35% |
---|---|---|---|
Sep 2023 | 78210000 | 11.46M | 14.66% |
Dec 2023 | 76185000 | 11.50M | 15.1% |
Mar 2024 | 73300000 | 11.55M | 15.77% |
Jun 2023 | -6.24M | 0 | 0 |
---|---|---|---|
Sep 2023 | -2.11M | 110K | 7.35M |
Dec 2023 | -1.89M | -6.55M | -65.33K |
Mar 2024 | -2.17M | 6.49M | 61.02K |
Acasti Pharma alternative data
Aug 2023 | 32 |
---|---|
Sep 2023 | 32 |
Oct 2023 | 32 |
Nov 2023 | 32 |
Dec 2023 | 32 |
Jan 2024 | 32 |
Feb 2024 | 32 |
Mar 2024 | 32 |
Apr 2024 | 32 |
May 2024 | 32 |
Jun 2024 | 32 |
Jul 2024 | 32 |
Acasti Pharma other data
Period | Buy | Sel |
---|---|---|
Aug 2023 | 381 | 0 |
Sep 2023 | 1099103 | 0 |
Patent |
---|
Application PROCESS OF PRODUCING CONCENTRATED THERAPEUTIC PHOSPHOLIPID COMPOSITION FROM KRILL EXTRACTS CONTAINING HIGH LEVEL OF FREE FATTY ACIDS Filling date: 7 Feb 2020 Issue date: 28 Apr 2022 |
Application Filling date: 9 May 2019 Issue date: 5 Aug 2021 |
Application Filling date: 15 May 2019 Issue date: 18 Mar 2021 |
Quarter | Transcript |
---|---|
Q3 2023 14 Feb 2023 | Q3 2023 Earnings Call Transcript |
Q2 2023 14 Nov 2022 | Q2 2023 Earnings Call Transcript |
Q1 2023 11 Aug 2022 | Q1 2023 Earnings Call Transcript |
Q4 2022 21 Jun 2022 | Q4 2022 Earnings Call Transcript |
Insider | Compensation |
---|---|
Ms. Janelle D'Alvise (1955) Pres, Chief Executive Officer, Corporation Sec. & Director | $428,040 |
Mr. Brian D. Ford CPA, CA (1959) Chief Financial Officer | $364,820 |
Dr. Pierre Lemieux M.D., Ph.D. (1965) Co-Founder, Chief Operating Officer & Chief Scientific Officer | $276,380 |
-
When is Acasti Pharma's next earnings date?
Unfortunately, Acasti Pharma's (ACST) next earnings date is currently unknown.
-
Does Acasti Pharma pay dividends?
No, Acasti Pharma does not pay dividends.
-
How much money does Acasti Pharma make?
Acasti Pharma has a market capitalization of 34.17M.
-
What is Acasti Pharma's stock symbol?
Acasti Pharma Inc. is traded on the NASDAQ under the ticker symbol "ACST".
-
What is Acasti Pharma's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Acasti Pharma?
Shares of Acasti Pharma can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Acasti Pharma's key executives?
Acasti Pharma's management team includes the following people:
- Ms. Janelle D'Alvise Pres, Chief Executive Officer, Corporation Sec. & Director(age: 70, pay: $428,040)
- Mr. Brian D. Ford CPA, CA Chief Financial Officer(age: 66, pay: $364,820)
- Dr. Pierre Lemieux M.D., Ph.D. Co-Founder, Chief Operating Officer & Chief Scientific Officer(age: 60, pay: $276,380)
-
Is Acasti Pharma founder-led company?
Yes, Acasti Pharma is a company led by its founder Dr. Pierre Lemieux M.D., Ph.D..
-
How many employees does Acasti Pharma have?
As Jul 2024, Acasti Pharma employs 32 workers.
-
When Acasti Pharma went public?
Acasti Pharma Inc. is publicly traded company for more then 13 years since IPO on 7 Feb 2012.
-
What is Acasti Pharma's official website?
The official website for Acasti Pharma is acastipharma.com.
-
Where are Acasti Pharma's headquarters?
Acasti Pharma is headquartered at 3009 boulevard de la Concorde East, Laval, QC.
-
How can i contact Acasti Pharma?
Acasti Pharma's mailing address is 3009 boulevard de la Concorde East, Laval, QC and company can be reached via phone at +45 06872262.
Acasti Pharma company profile:

Acasti Pharma Inc.
acastipharma.comNASDAQ
32
Biotechnology
Healthcare
Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.
Laval, QC H7E 2B5
CIK: 0001444192
ISIN: CA00430K8656
CUSIP: 00430K402